Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis

被引:43
|
作者
Baldwin, RL
Tran, H
Karlan, BY
机构
[1] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Burns & Allen Res Inst, Div Gynecol Oncol, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Los Angeles, CA 90048 USA
关键词
Fas; apoptosis; ovary; cancer; primary culture;
D O I
10.1006/gyno.1999.5448
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Fas, a primary mediator of cellular apoptosis, is expressed by the normal ovarian epithelium. We analyzed the levels of Fas and soluble Fas (sFas) expression in ovarian cancer tissue and determined the susceptibility of primary ovarian cancer cell (CSOC) cultures to Fas-mediated apoptosis. Methods. Fas mRNA levels were detected by RT-PCR, and Fas protein levels were determined by immunohistochemistry and Western blot analysis. Secreted sFas levels were measured by ELISA. Localization of Fas to the cell surface was demonstrated by flow cytometry. The effect of Fas on cell proliferation was measured by MTT assay. Results. Intense Las staining was detected on the cell surface and in the cytoplasm of ovarian carcinoma specimens. We also found that mean levels of sFas, which can function as a Fas agonist, were significantly increased in 18 sera from cancer patients (0.98 ng/ml) compared to those of 8 healthy individuals (0.61 ng/ml, P = 0.004). Fas mRNA and protein were expressed in all primary ovarian cancer cell cultures. Despite abundant Fas expression, CSOC cultures were significantly less sensitive to Fas-mediated apoptosis (11.3%) than primary cultures of normal ovarian epithelial cells (HOSE) (50.0%) (P = 0.00001). The sFas level in CSOC-conditioned medium was minimal (0.07 ng/ml) and not significantly different from that of HOSE-conditioned medium (0.09 ng/ml). The small amount of sFas secreted by CSOC does not likely account for the observed resistance to Fas-mediated apoptosis. Conclusion. Decreased sensitivity to Fas-mediated apoptosis could contribute to ovarian tumorigenesis through resistance to cytotoxic T lymphocyte-mediated cytotoxicity and may play a role in ovarian tumorigenesis. (C) 1999 Academic Press.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 50 条
  • [31] Fas-mediated apoptosis in accelerated graft arteriosclerosis
    Moldovan N.I.
    Qian Z.
    Chen Y.
    Dong C.
    Ying A.
    Hruban R.H.
    Flavahan N.A.
    Baldwin III W.M.
    Sanfilippo F.
    Goldschmidt-Clermont P.J.
    [J]. Angiogenesis, 1998, 2 (3) : 245 - 254
  • [32] Thyroid carcinoma cells and Fas-mediated apoptosis
    Mitsiades, CS
    Mitsiades, N
    [J]. THYROID, 2005, 15 (02) : 178 - 179
  • [33] JNK activation is not required for Fas-mediated apoptosis
    Walter Low
    Anna Smith
    Alan Ashworth
    Mary Collins
    [J]. Oncogene, 1999, 18 : 3737 - 3741
  • [34] Pirin Inhibits FAS-Mediated Apoptosis to Support Colorectal Cancer Survival
    Ma, Huanhuan
    Suleman, Muhammad
    Zhang, Fengqiong
    Cao, Tingyan
    Wen, Shixiong
    Sun, Dachao
    Chen, Lili
    Jiang, Bin
    Wang, Yue
    Lin, Furong
    Wang, Jinyang
    Li, Boan
    Li, Qinxi
    [J]. ADVANCED SCIENCE, 2024, 11 (10)
  • [35] Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer
    Lee, SH
    Kim, HS
    Kim, SY
    Lee, YS
    Park, WS
    Kim, SH
    Lee, JY
    Yoo, NJ
    [J]. APMIS, 2003, 111 (02) : 309 - 314
  • [36] Fas-mediated apoptosis in mouse osteoclasts.
    Wu, X
    McKenna, M
    Feng, X
    McDonald, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S271 - S271
  • [37] Fas-mediated apoptosis in cultured human eosinophils
    Druilhe, A
    Cai, ZZ
    Haile, S
    Chouaib, S
    Pretolani, M
    [J]. BLOOD, 1996, 87 (07) : 2822 - 2830
  • [38] Effects of anticancer drugs on Fas-mediated apoptosis in cancer cells.
    Iwase, M
    Watanabe, H
    Ohashi, M
    Nagumo, M
    [J]. JOURNAL OF DENTAL RESEARCH, 2000, 79 (05) : 1239 - 1239
  • [39] Fas-mediated apoptosis in acute alcoholic hepatitis
    Tagami, A
    Ohnishi, H
    Moriwaki, H
    Phillips, M
    Hughes, RD
    [J]. HEPATO-GASTROENTEROLOGY, 2003, 50 (50) : 443 - 448
  • [40] Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas
    Legembre, P
    Moreau, P
    Daburon, S
    Moreau, JF
    Taupin, JL
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (03): : 329 - 339